Regulatory filing and review delays keep Truvada as pre-exposure prophylaxis out of reach of those who need it most By Scott Morgan Pre-exposure prophylaxis (PrEP) is the use of antiretroviral medication to prevent HIV acquisition. The U.S. Food and Drug…
In Defense of Stringency: In response to growing public concern with health risks posed by approved drugs, a 2006 landmark report by the Institute of Medicine (IOM) argued that the U.S. Food and Drug Administration (FDA) lacks the unambiguous authority necessary to ensure the safety and efficacy of the country’s medicinal products.
Letter signed by a number of organizations and individuals urging Gilead to consider drug pricing that addresses the need for cost-contained HIV care delivery in the U.S.
In response to disturbing trends in New York City’s response to the ongoing HIV and STD epidemics, ACT UP\New York and Treatment Action Group (TAG) will host a town hall meeting at the New York City
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development.
An objective of the National HIV/AIDS Strategy (NHAS), released by the White House in July 2010, is to lower the annual number of new infections in the United States by 25 percent by the end of 2015.
An Op-Ed written by Gregg Gonsalves, Mark Harrington, and David A. Kessler.
May 2015 Examples of media coverage: Gilead Sciences (GILD) May Have Found A Cure For HIV! – CNA Finance, May 18, 2015 This Experimental Drug Could Finally Cure HIV – Motley Fool, May 18, 2015 Original source: Unknown, possibly a…
New York, NY– Governor Cuomo formally accepted the long-awaited Blueprint to End AIDS at a public event on Wednesday, marking an important step towards fulfilling his commitment to end AIDS in New York State.
TAG & Housing Works Report Shows Plan To End AIDS By 2020 Will Translate Into $4.5 Billion In Net Medicaid Savings For NY State.